Safety Shot, Inc. Developing Next-Generation Nootropic and Sleep Solutions by leveraging Core 'Feel Better Fast' Expertise

Rhea-AI Summary

Safety Shot (NASDAQ: SHOT), known for its blood alcohol-reducing supplement Sure Shot, announced expansion into nootropics and sleep aid markets. The company plans to leverage its expertise in rapid wellness solutions to develop cognitive enhancement and sleep improvement products. The R&D initiative builds on Sure Shot's foundational principles of boosting clarity, energy, and mood. The global nootropics market, valued at $6.5 billion, is projected to reach $14.9 billion by 2034 (8.7% CAGR), while the sleep supplements market, valued at $6.8 billion, is expected to hit $11.8 billion by 2034 (5.1% CAGR). Led by CEO Jarrett Boon and COO David Sandler, Safety Shot aims to create unique formulations focusing on efficacy and tangible results, with product prototypes expected later this year.

Positive

• Expansion into two high-growth markets: nootropics (8.7% CAGR) and sleep aids (5.1% CAGR)
• Leveraging existing expertise and technology from Sure Shot product development
• Combined target market opportunity of over $26.7 billion by 2034
• Development led by experienced management team with focus on scientific efficacy

Negative

• Products still in early R&D phase with no immediate revenue impact
• Entering highly competitive markets with established players
• No specific timeline or revenue projections provided
• Potential R&D costs and time to market uncertainty

Insights

Biotech Product Development Strategist

Safety Shot's expansion into nootropics and sleep aids leverages existing expertise, targeting high-growth markets worth $13.3B combined.

Safety Shot is making a strategic pivot to expand beyond its alcohol metabolism product into two complementary wellness categories with substantial market potential. The company is leveraging its existing scientific foundation in developing Sure Shot™ to create cognitive enhancement and sleep aid products, extending its "Feel Better Fast" brand promise into daily wellness applications.

This strategic expansion targets two significant market opportunities: the nootropics market ($6.5 billion growing to $14.9 billion by 2034 at 8.7% CAGR) and the sleep supplement market ($6.8 billion growing to $11.8 billion by 2034 at 5.1% CAGR). These markets align well with Safety Shot's existing expertise in rapid-onset wellness formulations.

The development approach centers on the company's self-described "over-engineering" philosophy, suggesting they aim to create premium, highly effective formulations rather than basic commodity supplements. For their sleep product, they specifically mention using "ingredients not typically found in most sleep aid products," indicating potential differentiation in a crowded market.

What makes this expansion particularly logical is that Sure Shot™ already incorporates elements that affect clarity, energy, and mood — making the extension into dedicated cognitive and sleep products a natural progression rather than a complete departure from core competencies. However, investors should note this represents an R&D announcement with prototypes expected "later this year" rather than an immediate product launch, meaning revenue impact will be delayed.

Company to Expand Patented Wellness Approach into High-Growth Cognitive and Restorative Sleep Markets, Emphasizing Scientific Rigor and Unique Formulations

SCOTTSDALE, AZ, June 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company known for Sure Shot^™, its patented product that rapidly lowers blood alcohol content by supporting its metabolism, today announced the initiation of research and development (R&D) for innovative new product lines. These forthcoming offerings will target the rapidly expanding market for nootropics – supplements designed to support cognitive function – and the growing demand for effective sleep and relaxation aids.

For those unfamiliar, nootropics, often referred to as “cognitive enhancers” or “smart drugs,” are substances formulated to support mental performance, including areas like focus, memory, creativity, and motivation. Safety Shot aims to bring its scientific acumen to this evolving space.

This strategic initiative significantly expands upon the scientific insights gained from developing Sure Shot^™. While Sure Shot^™ is primarily designed to support alcohol metabolism, it is also uniquely formulated to boost clarity, energy, and overall mood. The Company will adapt these foundational principles to create specialized products aimed at daily cognitive enhancement and restorative sleep, extending its "Feel Better Fast" promise. Safety Shot plans to release these new products in the coming months.

“Our mission at Safety Shot has always been to help people feel better and function at their best, leveraging science to create effective solutions,” said Jarrett Boon, CEO of Safety Shot. “Expanding into dedicated nootropic and sleep categories is a natural progression, allowing us to apply our core competencies to address broader consumer needs.”

David Sandler, Chief Operating Officer and Scientific Director of Safety Shot, elaborated on the Company's development philosophy: "Safety Shot has an over-engineering thought process so that we know our products work, and we are dedicated to being the top performer of products in the marketplace. Our commitment is to efficacy and tangible results for our customers."

The new R&D efforts will focus on:

• Nootropics: Creating a stand-alone product specifically engineered to enhance focus, dial-in cognition, and support executive function, while also contributing to overall brain health for daily use.
  
  
• Sleep Aids: Recognizing the critical role of sleep in daily productivity, mental clarity, and overall health, Safety Shot is developing an industry-leading sleep solution. Health authorities like the CDC recommend that adults aim for 7 or more hours of quality sleep per night, yet more than a third of American adults report getting less. The consequences of insufficient sleep are well-documented, with even short-term deprivation leading to impaired attention, decision-making, and reaction times. Chronic sleep loss can significantly impact memory, learning, and overall productivity. Safety Shot’s sleep aid, anticipated in tablet, drop, or powder form, will aim to improve sleep quality and duration. The goal is to help users achieve the deep, restorative sleep necessary to wake feeling genuinely refreshed, mentally sharp, and ready to perform optimally. According to Mr. Sandler, the formulation will feature a "unique twist by using ingredients not typically found in most sleep aid products," aiming for enhanced efficacy.
  

Future Market Insights reports the Global Nootropics Supplements market is valued at approximately $6.5 billion and is projected to surpass $14.9 billion by 2034 (CAGR of 8.7%). In 2023, Allied Research reported a market value of $6.8 billion in sleep-related supplements, with an anticipated CAGR of 5.1%, reaching an annual revenue of $11.8 billion by 2034.

Mr. Boon added, “we are excited by the potential of these new products. Our R&D team is focused on leveraging advanced technologies to create solutions that offer distinct advantages. As leaders in rapid wellness improvement, Safety Shot is well-positioned to gain substantial market share.”

The development phase is currently underway, with prototypes expected later this year.

About Safety Shot, Inc.

Safety Shot Inc., a wellness and dietary supplement company, has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon. Safety Shot is introducing business-to-business sales of Sure Shot to distributors, retailers, restaurants, and bars throughout 2025.

Investor Relations
CoreIR
Phone: 516-222-2560
Email: investors@drinksafetyshot.com

Media Contact:
CORE IR
Jules Abraham
516 222 2560
julesa@coreir.com

Forward-Looking Statements

This press release contains forward-looking statements that are based on current expectations and involve a number of risks and uncertainties. These statements include, but are not limited to, statements regarding the development and release of new products, the potential market share Safety Shot, Inc. may gain, and the projected growth of the nootropics and sleep supplement markets. Actual results may differ materially from those indicated in such forward-looking statements as a result of various important factors, including the ability of the Company to successfully develop and commercialize new products, market acceptance of these products, competition in the marketplace, and other factors discussed in the "Risk Factors" section of the Company’s most recent Annual Report on Form 10-K and other periodic reports filed with the Securities and Exchange Commission. Safety Shot, undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

FAQ

What new products is Safety Shot (SHOT) developing in 2025?

Safety Shot is developing nootropic supplements for cognitive enhancement and sleep aid solutions, leveraging their expertise from their Sure Shot alcohol metabolism product.

What is the market size for nootropics that Safety Shot (SHOT) is targeting?

The Global Nootropics Supplements market is valued at $6.5 billion and is projected to reach $14.9 billion by 2034, growing at a CAGR of 8.7%.

When will Safety Shot (SHOT) release their new nootropic and sleep products?

The company is currently in the R&D phase with prototypes expected later in 2025, but specific release dates haven't been announced.

How big is the sleep supplement market that Safety Shot (SHOT) is entering?

The sleep supplement market was valued at $6.8 billion in 2023 and is expected to reach $11.8 billion by 2034, with a 5.1% CAGR.

What is Safety Shot's (SHOT) approach to product development?

Safety Shot emphasizes an over-engineering approach focused on efficacy and tangible results, with commitment to being the top performer in the marketplace.